ATE552001T1 - Stephaglabrinsulfat umfassende pharmazeutische zubereitung zur behandlung von demyelinierenden erkrankungen des nervensystems und zur förderung der wiederherstellung der myelinscheide von nervenfasern - Google Patents

Stephaglabrinsulfat umfassende pharmazeutische zubereitung zur behandlung von demyelinierenden erkrankungen des nervensystems und zur förderung der wiederherstellung der myelinscheide von nervenfasern

Info

Publication number
ATE552001T1
ATE552001T1 AT08859308T AT08859308T ATE552001T1 AT E552001 T1 ATE552001 T1 AT E552001T1 AT 08859308 T AT08859308 T AT 08859308T AT 08859308 T AT08859308 T AT 08859308T AT E552001 T1 ATE552001 T1 AT E552001T1
Authority
AT
Austria
Prior art keywords
nervous
restoration
demyelinating diseases
nervous system
sheath
Prior art date
Application number
AT08859308T
Other languages
English (en)
Inventor
Evgeny Veniaminovich Arzamastsev
Klavdia Ignatievna Malinovskaya
Margarita Ivanovna Mironova
Original Assignee
Sbiogen Technologiess Aozt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbiogen Technologiess Aozt filed Critical Sbiogen Technologiess Aozt
Application granted granted Critical
Publication of ATE552001T1 publication Critical patent/ATE552001T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT08859308T 2007-12-06 2008-12-05 Stephaglabrinsulfat umfassende pharmazeutische zubereitung zur behandlung von demyelinierenden erkrankungen des nervensystems und zur förderung der wiederherstellung der myelinscheide von nervenfasern ATE552001T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2007145037/15A RU2355413C1 (ru) 2007-12-06 2007-12-06 Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы, средство, способствующее восстановлению миелиновой оболочки нервного волокна, и способ лечения демиелинизирующих заболеваний нервной системы
PCT/RU2008/000747 WO2009075607A2 (en) 2007-12-06 2008-12-05 Pharmaceutical preparation for treating demyelinating diseases of the nervous system; preparation promoting restoration of the myelin sheath of nerve fibers; and a method for treating demyelinating diseases of the nervous system

Publications (1)

Publication Number Publication Date
ATE552001T1 true ATE552001T1 (de) 2012-04-15

Family

ID=40756011

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08859308T ATE552001T1 (de) 2007-12-06 2008-12-05 Stephaglabrinsulfat umfassende pharmazeutische zubereitung zur behandlung von demyelinierenden erkrankungen des nervensystems und zur förderung der wiederherstellung der myelinscheide von nervenfasern

Country Status (18)

Country Link
US (2) US8440683B2 (de)
EP (1) EP2271340B1 (de)
JP (1) JP5485166B2 (de)
KR (1) KR20100113505A (de)
CN (1) CN101888842B (de)
AT (1) ATE552001T1 (de)
CA (1) CA2707681C (de)
CY (1) CY1112818T1 (de)
DK (1) DK2271340T3 (de)
EA (1) EA201000786A1 (de)
ES (1) ES2383315T3 (de)
HR (1) HRP20120422T1 (de)
PL (1) PL2271340T3 (de)
PT (1) PT2271340E (de)
RU (1) RU2355413C1 (de)
SI (1) SI2271340T1 (de)
UA (1) UA97875C2 (de)
WO (1) WO2009075607A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102526648B1 (ko) * 2015-08-21 2023-04-27 삼성전자주식회사 2,5-디히드록시벤젠술폰산을 포함하는 신경세포의 수초화를 촉진하기 위한 조성물 및 그의 용도
SG11202006374VA (en) 2018-01-11 2020-07-29 M et P Pharma AG Treatment of demyelinating diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU315388A1 (ru) * 1963-02-04 1977-09-05 Всесоюзный Научно-Исследовательский Институт Лекарственных И Ароматических Растений Лекарственное средство
SU856462A1 (ru) * 1979-07-18 1981-08-23 Одесский Медицинский Институт Им.Н.И.Пирогова Способ лечени больных с двигательными церебральными расстройствами
RU1713151C (ru) * 1986-07-05 1995-02-09 Научно-производственное объединение "ВНИИ лекарственных и ароматических растений" Средство для лечения травматических и послеоперационных повреждений периферической нервной системы
RU2089610C1 (ru) 1994-03-29 1997-09-10 Институт физиологии растений им.К.А.Тимирязева РАН Штамм культивируемых клеток растенийй stephania glabra (roxb) miers - продуцент стефарина
RU2179009C2 (ru) * 1998-02-06 2002-02-10 Предприятие "Васиа" Способ и устройство для реабилитации нервной, мышечной и двигательной координации больных с нарушениями центральной нервной системы
AU2002246619A1 (en) 2000-12-08 2003-06-23 Neuronz Limited Use of insuline-like growth factor-i for promoting remyelination of axons
WO2003041655A2 (en) 2001-11-13 2003-05-22 Loi Tran Therapeutic agent composition and method of use

Also Published As

Publication number Publication date
JP5485166B2 (ja) 2014-05-07
RU2355413C1 (ru) 2009-05-20
WO2009075607A3 (en) 2009-10-29
KR20100113505A (ko) 2010-10-21
US20130226133A1 (en) 2013-08-29
PT2271340E (pt) 2012-06-01
CY1112818T1 (el) 2016-02-10
HRP20120422T1 (hr) 2012-06-30
JP2011506316A (ja) 2011-03-03
SI2271340T1 (sl) 2012-07-31
UA97875C2 (ru) 2012-03-26
ES2383315T3 (es) 2012-06-20
EA201000786A1 (ru) 2010-12-30
DK2271340T3 (da) 2012-06-11
CA2707681A1 (en) 2009-06-18
US8440683B2 (en) 2013-05-14
WO2009075607A2 (en) 2009-06-18
EP2271340A2 (de) 2011-01-12
EP2271340B1 (de) 2012-04-04
PL2271340T3 (pl) 2012-09-28
CN101888842B (zh) 2012-07-04
CN101888842A (zh) 2010-11-17
US20100267756A1 (en) 2010-10-21
CA2707681C (en) 2013-01-08

Similar Documents

Publication Publication Date Title
EA201791669A3 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
EA201000603A1 (ru) ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ
MX2011007854A (es) Metodos para tratar infartos agudos al miocardio y trastornos relacionados.
EA200800157A1 (ru) Антагонисты npy, способ их получения и применение
EA201200686A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера
EA201370208A1 (ru) Формы рифаксимина и их применение
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
WO2009038720A3 (en) Method and apparatus for applying light therapy
EA201590655A8 (ru) Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений
JO3267B1 (ar) بيرولات [3، 4-سي] اوكتاهيدروبيرولو ثنائية الاستبدال كمعدلات لمستقبل اوريكسين
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
BR112012009121A2 (pt) Novas composições para a prevenção e/ou tratamento de distúrbios degenerativos do sistema nervoso central
EA201300988A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
WO2008090287A3 (fr) Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida
ATE555131T1 (de) Verfahren zur behandlung von erkrankungen mit knochenabbau unter verwendung eines gm-csf- antagonisten
MX2009013197A (es) Derivados terapeuticos de pirazolonaftiridina.
EA200970436A1 (ru) Соединения карбамата для лечения депрессии
MX2009013202A (es) Derivados terapeuticos de pirazoloquinolina.
SI2271340T1 (sl) Farmacevtski pripravek ki obsega stefaglabrin sulfat za zdravljenje demielinizacijskih bolezni živčnega sistema in za pospešitev obnovitve mielinske ovojnice živčnih vlaken
EP4452393A4 (de) Stimulation des okzipitalen nerven zur behandlung von schmerzen
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
EP4479060A4 (de) 3alpha-oh-5beta-pregnan-20-on-zusammensetzungen und verfahren zur behandlung von erkrankungen des zentralnervensystems
EP4469490A4 (de) Zusammensetzungen, vorrichtungen und verfahren zur behandlung von zns-erkrankungen